Posted 2/12/2015 11:51 PM (GMT -5)
As suggested by Wampuscat (Marie) and Adjust (Don) I went to NIH for an acceptance screening to be in a trial to compare enzalutamide to enzalutimide with prostvac vaccine. I was accepted into the trial but did not get the vaccine cohort. I will be on the med only. The screen consisted of several scans... CT (chest, abdomen, and pelvis), nuclear bone scan, and PET bone scan as well as extensive blood and urine analysis. I do not think I have had such a thorough evaluation of my status at any time during my treatment.
One thing that has bothered me for some time has been the nagging feeling that my radiation treatment was flawed somehow. After this evaluation I see that it was very successful in eliminating any cancer in my prostate and the two local pelvic lymph nodes that were questionable at diagnosis as that area showed no activity. So, now I know that the genie was already out of the bottle and my original decision was good.
The chest scan confirmed my lung mets and at least one swollen lymp node in that area. Likely spread through my lymphatic system. (my opinion) The lung mets appear to be stable from previous scans and some are necrotic. I am hoping the enzalutamide will help in this area. One of the doctors mentioned that lung mets were fairly rare as a first location.
My bone scans continue to be clear.
I also met with the doctors who are conducting the study and we were all a bit dissappointed when I did not draw the vaccine arm of the study. I was pretty excited by what I heard regarding that potential treatment.
All in all a worthwihile visit and I look forward to participating in the trial. It will be well worth the travel just for the frequency and depth of the analysis. I feel fortunate to be part of this.
Once again, thanks to Marie and Don for thier prompting and contact information about the trial.
Don